FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Metoprolol Succinate

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot #: 21143093, Exp. March 2023
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Dissolution Specifications.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byAlkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054 foreign manufacturer
Brand nameMETOPROLOL SUCCINATE
Generic nameMETOPROLOL SUCCINATE ER TABLETS
Active ingredient(s)METOPROLOL SUCCINATE
Distributed by / forAscend Laboratories, LLC, Parsippany, NJ, 07054
NDC67877-590-01
Show the full FDA record
Full product labelMetoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.
Recalling firmAscend Laboratories, LLC
DistributionNationwide in the USA
Quantity9216 bottles
Recall initiated2022-01-12
Report date2022-02-02
Recall completed2023-05-31
Recall numberD-0393-2022
ClassificationClass II
FDA statusTerminated
Origin on fileParsippany NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.